Variation in the tumor necrosis factor-α gene promoter region may be associated with death from meningococcal disease

Journal of Infectious Diseases

Volumn 174, Issue 4, 1996, Pages 878-880

  Nadel, Simon ^a,b   Newport, Melanie J ^a,c   Booy, Robert ^a   Levin, Michael ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c MRC Research Laboratories   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; DISEASE SEVERITY; GENETIC VARIABILITY; HOST RESISTANCE; HUMAN; HUMAN TISSUE; MENINGOCOCCOSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0029815192     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.4.878     Document Type: Article

References (13)

1. Lynn WA, Cohen J. Adjunctivc therapy for septic shock: a review of experimental approaches. Clin Infect Dis 1995;20:143-58.
2. Waage A, Halstensen A, Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987;1:355-7.
3. Nadel S, Levin M, Habibi P. Treatment of meningococcal disease in childhood, In: Cartwright K, ed. Meningococcal disease. Chichester: John Wiley & Sons, 1995:207-43.
4. Kwiatkowski D, Hill AVS, Sambou I, et al. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 1990;336:1201-4.
5. Pociot F, Briant L, Jongeneel CV, et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993;23:224-31.
6. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LBA, Duff GW. An allelic polymorphism within the human tumor necrosis factor a promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993;177:557-60.
7. Wilson AG, Symons JA, McDowell TL, di Giovine FS, Duff GW. Effects of a tumour necrosis factor (TNFα) promoter base transition on transcriptional activity. Br J Rheumatol 1994;33(suppl 1):89.
8. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508-11.
9. Pollack MM, Ruttiman UE, Getson PR. Pediatric risk of mortality (PRISM) score. Crit Care Med 1988;16:1110-6.
10. Algren JT, Lal S, Cutliff SA, Richman BJ. Predictors of outcome in acute meningococcal infection in childhood. Crit Care Med 1993;21:447-52.
11. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
12. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumour necrosis factor α (TNFα) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992;1:353.
13. Zervas J, Valassi-Adam H, Constandopoulos C. Histocompatibility leukocyte antigens in children with meningococcal meningitis. J Infect Dis 1981;143:854.